<code id='AF4DAA6E85'></code><style id='AF4DAA6E85'></style>
    • <acronym id='AF4DAA6E85'></acronym>
      <center id='AF4DAA6E85'><center id='AF4DAA6E85'><tfoot id='AF4DAA6E85'></tfoot></center><abbr id='AF4DAA6E85'><dir id='AF4DAA6E85'><tfoot id='AF4DAA6E85'></tfoot><noframes id='AF4DAA6E85'>

    • <optgroup id='AF4DAA6E85'><strike id='AF4DAA6E85'><sup id='AF4DAA6E85'></sup></strike><code id='AF4DAA6E85'></code></optgroup>
        1. <b id='AF4DAA6E85'><label id='AF4DAA6E85'><select id='AF4DAA6E85'><dt id='AF4DAA6E85'><span id='AF4DAA6E85'></span></dt></select></label></b><u id='AF4DAA6E85'></u>
          <i id='AF4DAA6E85'><strike id='AF4DAA6E85'><tt id='AF4DAA6E85'><pre id='AF4DAA6E85'></pre></tt></strike></i>

          fashion

          fashion

          author:knowledge    Page View:611
          Colorful one hundred dollar bills -- health tech coverage from STAT
          Adobe

          Hospitals aren’t usually in the business of selling technology tools. But that’s changing thanks to a collision of financial pressures and an explosion of new technology that could both improve patients’ health and ease the burden of administrative tasks on limited staff.

          At the J.P. Morgan Healthcare conference, an exclusive, invitation-only event for investors, several influential health systems like Mayo Clinic and Mass General Brigham doubled down on new revenue streams including advising companies building artificial intelligence tools or licensing out custom built products as they brace for a tough 2024.

          advertisement

          Selling tech isn’t entirely new: a subset of hospitals and academic centers have been licensing out risk models and health record tools for decades. But now, a “perfect storm” of shrinking profit margins and philanthropic dollars, workforce shortages and rising labor costs is driving more hospitals to explore selling new technology they have built, like scheduling or clinical note summary tools, more than they have before, according to Dana Rollison, chief data officer at Moffitt Cancer Center.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more
          Study suggests new cause of Down syndrome: cells linked to aging
          Study suggests new cause of Down syndrome: cells linked to aging

          NeuralprogenitorcellsderivedfromstemcellsofapersonwithDownsyndrome.CourtesyHiruyMeharenaDownsyndrome

          read more
          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more

          How state and local governments are sidelining science

          AhelicopterfliesaboveHoustonaweekafterHurricaneHarveyfloodedthearea.JustinSullivan/GettyImagesInlate